Paul Hamilton
Keine laufenden Positionen mehr
Profil
Paul Hamilton is Vice President of Research and Development for Affinergy, Inc. Prior to joining Affinergy, he was Vice President of Research and Development and Site Manger of (now known as Karo Bio USA, Inc.) from 2000 to 2004.
Previously, Dr. Hamilton worked at Becton Dickinson & Co. for 11 years.
He has over 19 years of industrial experience in both diagnostic and therapeutic companies.
Dr. Hamilton received a PhD in Microbiology from the Ohio State University in 1984.
Ehemalige bekannte Positionen von Paul Hamilton
Unternehmen | Position | Ende |
---|---|---|
Karo Bio USA, Inc.
Karo Bio USA, Inc. Miscellaneous Commercial ServicesCommercial Services Karo Bio USA, Inc. develops drug discovery technologies. It develops screening assays and drugs that work upon nuclear receptors. The company is headquartered in Chapel Hill, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Affinergy LLC
Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Paul Hamilton
The Ohio State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BECTON, DICKINSON AND COMPANY | Health Technology |
Private Unternehmen | 2 |
---|---|
Affinergy LLC
Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Health Technology |
Karo Bio USA, Inc.
Karo Bio USA, Inc. Miscellaneous Commercial ServicesCommercial Services Karo Bio USA, Inc. develops drug discovery technologies. It develops screening assays and drugs that work upon nuclear receptors. The company is headquartered in Chapel Hill, NC. | Commercial Services |